Ohmori, Tsukasa, et al. «CRISPR / Cas9 - mediated genome editing via postnatal administration of AAV vector
cures haemophilia B mice.»
Cellectis, the French genome engineering specialist, and VIB together conduct research into new approaches to
cure haemophilia.
Not exact matches
Clotting - factor infusions treat symptoms of
haemophilia, but gene therapy could provide a
cure.
Shire CEO Flemming Ornskov - who has a large conventional
haemophilia business and is also chasing Biomarin and Spark in hunting a
cure for the bleeding disorder - sees both the opportunities and the difficulties of gene therapy.
Repairing the faulty genes that cause
haemophilia could ultimately
cure the disease, but it will be a tough challenge
A «
cure» for
haemophilia is one step closer, following results published in the New England Journal of Medcine of a groundbreaking gene therapy trial led by the NHS in London.